Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 09, 2022

SELL
$4.83 - $7.35 $377,908 - $575,078
-78,242 Closed
0 $0
Q4 2021

Feb 01, 2022

BUY
$6.16 - $12.07 $287,160 - $562,667
46,617 Added 147.41%
78,242 $545,000
Q3 2021

Nov 12, 2021

SELL
$9.7 - $14.34 $633,856 - $937,061
-65,346 Reduced 67.39%
31,625 $316,000
Q2 2021

Aug 13, 2021

BUY
$13.43 - $19.16 $1.02 Million - $1.46 Million
76,202 Added 366.9%
96,971 $1.38 Million
Q1 2021

May 14, 2021

BUY
$15.82 - $22.11 $328,565 - $459,202
20,769 New
20,769 $341,000
Q3 2020

Nov 12, 2020

SELL
$7.36 - $9.87 $326,408 - $437,724
-44,349 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$4.67 - $8.95 $207,109 - $396,923
44,349 New
44,349 $369,000

Others Institutions Holding OCUL

About OCULAR THERAPEUTIX, INC


  • Ticker OCUL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,966,896
  • Market Cap $654M
  • Description
  • Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...
More about OCUL
Track This Portfolio

Track Qube Research & Technologies LTD Portfolio

Follow Qube Research & Technologies LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.